Dlugosz Paula, Tresky Roland, Nimpf Johannes
Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University Vienna, Vienna, Austria.
Front Mol Neurosci. 2019 Feb 26;12:53. doi: 10.3389/fnmol.2019.00053. eCollection 2019.
The canonical Reelin signaling cascade regulates correct neuronal layering during embryonic brain development. Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). The receptors are expressed in different variants in different areas of the developing brain. Binding of Reelin and its central fragment to the receptors results in phosphorylation of the intracellular adapter disabled-1 (Dab1) in neurons. Here, we studied the changes of the arrangement of the receptors upon Reelin binding and its central fragment at the molecular level in human embryonic kidney 293 (HEK293) cells by time-resolved anisotropy and fluorescence lifetime imaging microscopy (FLIM). In the off-state of the pathway ApoER2 and VLDLR form homo or hetero-di/oligomers. Upon binding of full length Reelin ApoER2 and VLDLR homo-oligomers are rearranged to higher order receptor clusters which leads to Dab1 phosphorylation. When the central fragment of Reelin binds to the receptors the cluster size of homo-oligomers is not affected and Dab1 is not phosphorylated. Hetero-oligomerization, however, can be induced, but does not lead to Dab1 phosphorylation. Cells expressing only ApoER2 or VLDLR change their shape when stimulated with the central fragment. Cells expressing ApoER2 produce filopodia/lamellipodia and cell size increases, whereas VLDLR-expressing cells decrease in size. These findings demonstrate that the primary event in the canonical Reelin pathway is the rearrangement of preformed receptor homo-oligomers to higher order clusters. In addition the possibility of yet another signaling mechanism which is mediated by the central Reelin fragment independent of Dab1 phosphorylation became apparent.
经典的Reelin信号级联反应在胚胎脑发育过程中调节神经元的正确分层。由于参与该途径的成分高度可变,并形成了相互作用分子的复杂混合物,因此该途径的细节仍未完全了解。Reelin经过蛋白水解加工,产生五个不同的片段,其中一些片段携带两种不同但高度同源的受体,即载脂蛋白E受体2(ApoER2)和极低密度脂蛋白受体(VLDLR)的结合位点。这些受体在发育中的大脑不同区域以不同变体形式表达。Reelin及其中心片段与受体结合会导致神经元内细胞内衔接蛋白失活-1(Dab1)磷酸化。在这里,我们通过时间分辨各向异性和荧光寿命成像显微镜(FLIM)在分子水平上研究了人胚肾293(HEK293)细胞中Reelin及其中心片段结合后受体排列的变化。在该途径的非激活状态下,ApoER2和VLDLR形成同型或异型二聚体/寡聚体。全长Reelin结合后,ApoER2和VLDLR同型寡聚体重排为更高阶的受体簇,从而导致Dab1磷酸化。当Reelin的中心片段与受体结合时,同型寡聚体的簇大小不受影响,Dab1也不发生磷酸化。然而,异型寡聚化可以被诱导,但不会导致Dab1磷酸化。仅表达ApoER2或VLDLR的细胞在用中心片段刺激时会改变其形状。表达ApoER2的细胞产生丝状伪足/片状伪足,细胞大小增加,而表达VLDLR的细胞大小减小。这些发现表明,经典Reelin途径中的主要事件是预先形成的受体同型寡聚体重排为更高阶的簇。此外,由Reelin中心片段介导的、独立于Dab1磷酸化的另一种信号机制的可能性也变得明显。